Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance
BMJ · 09.05.2024 · q807
DOI: 10.1136/bmj.q807 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, online erschienen am 09.05.2024. Verfasst von Eric Slade und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health and Care Excellence, London eric.slade@nice.org.uk r.manchanda@qmul.ac.uk. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Institute for Health and Care Excellence, London eric.slade@nice.org.uk r.manchanda@qmul.ac.uk.
- National Institute for Health and Care Excellence, London.
- Wolfson Institute of Population Health, Queen Mary University of London eric.slade@nice.org.uk r.manchanda@qmul.ac.uk.
- Barts Health NHS Trust, Royal London Hospital.
- Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine.
Zitieren
APA
Slade, E., Berg, L., Dworzynski, K., Manchanda, R., & Guideline Committee (2024). Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance. BMJ, q807. https://doi.org/10.1136/bmj.q807
Vancouver
Slade E, Berg L, Dworzynski K, Manchanda R, Guideline Committee. Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance. BMJ. 2024:q807. doi:10.1136/bmj.q807
BibTeX
@article{Slade2024,
author = {Slade, Eric and Berg, Laura and Dworzynski, Katharina and Manchanda, Ranjit and Guideline Committee, Guideline Committee},
title = {Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance},
journal = {BMJ},
year = {2024},
pages = {q807},
doi = {10.1136/bmj.q807}
}
EUVIMED